Documented 0 10 0 10 O
or 11 13 11 13 O
presumed 14 22 14 22 O
( 23 24 23 24 O
or 24 26 24 26 O
at 27 29 27 29 O
risk 30 34 30 34 O
of 35 37 35 37 O
) 37 38 37 38 O
bacterial 39 48 39 48 B-chronic_disease
infections 49 59 49 59 I-chronic_disease
, 59 60 59 60 O
and 61 64 61 64 O
currently 65 74 65 74 O
receiving 75 84 75 84 O
antibiotic 85 95 85 95 B-treatment
treatment 96 105 96 105 I-treatment

Expected 0 8 106 114 O
to 9 11 115 117 O
survive 12 19 118 125 O
beyond 20 26 126 132 O
the 27 30 133 136 O
first 31 36 137 142 O
7 37 38 143 144 B-upper_bound
days 39 43 145 149 I-upper_bound
after 44 49 150 155 I-upper_bound
enrolment 50 59 156 165 O

HIV 0 3 166 169 B-chronic_disease
or 4 6 170 172 O
other 7 12 173 178 O
congenital 13 23 179 189 B-chronic_disease
viral 24 29 190 195 B-chronic_disease
or 30 32 196 198 O
fungal 33 39 199 205 B-chronic_disease
infection 40 49 206 215 I-chronic_disease

Impaired 0 8 216 224 B-chronic_disease
renal 9 14 225 230 I-chronic_disease
function 15 23 231 239 I-chronic_disease
or 24 26 240 242 O
known 27 32 243 248 O
significant 33 44 249 260 O
renal 45 50 261 266 B-chronic_disease
disease 51 58 267 274 I-chronic_disease

Major 0 5 275 280 B-chronic_disease
birth 6 11 281 286 I-chronic_disease
defect 12 18 287 293 I-chronic_disease
or 19 21 294 296 O
malformation 22 34 297 309 B-chronic_disease
syndrome 35 43 310 318 I-chronic_disease

Neonates 0 8 319 327 O
and 9 12 328 331 O
infants 13 20 332 339 O
≤3 21 23 340 342 O
months 24 30 343 349 I-upper_bound
, 30 31 349 350 O
with 32 36 351 355 O
gestational 37 48 356 367 B-clinical_variable
age 49 52 368 371 I-clinical_variable
≥28 53 56 372 375 O
weeks 57 62 376 381 I-lower_bound

Proven 0 6 382 388 O
presence 7 15 389 397 O
of 16 18 398 400 O
an 19 21 401 403 O
immunodeficiency 22 38 404 420 B-chronic_disease

Significant 0 11 421 432 O
laboratory 12 22 433 443 O
abnormalities 23 36 444 457 O
including 37 46 458 467 O
: 46 47 467 468 O
Haematocrit 48 59 469 480 B-clinical_variable
< 60 61 481 482 O
20 61 63 482 484 B-upper_bound
% 63 64 484 485 I-upper_bound
; 64 65 485 486 O
Absolute 66 74 487 495 B-clinical_variable
neutrophil 75 85 496 506 I-clinical_variable
count 86 91 507 512 I-clinical_variable
< 92 93 513 514 O
0.5x10⁹/L 93 102 514 523 B-upper_bound
; 102 103 523 524 O
Platelet 104 112 525 533 B-clinical_variable
count 113 118 534 539 I-clinical_variable
< 119 120 540 541 O
50x10⁹/L 121 129 542 550 B-upper_bound
; 129 130 550 551 O
Alanine 131 138 552 559 B-clinical_variable
aminotransferase 139 155 560 576 I-clinical_variable
or 156 158 577 579 O
aspartate 159 168 580 589 B-clinical_variable
aminotransferase 169 185 590 606 I-clinical_variable
> 186 187 607 608 O
3 187 188 608 609 B-lower_bound
times 189 194 610 615 I-lower_bound
the 195 198 616 619 I-lower_bound
age 199 202 620 623 I-lower_bound
- 202 203 623 624 I-lower_bound
specific 203 211 624 632 I-lower_bound
upper 212 217 633 638 I-lower_bound
limit 218 223 639 644 I-lower_bound
of 224 226 645 647 I-lower_bound
normal 227 233 648 654 I-lower_bound

Sufficient 0 10 655 665 O
vascular 11 19 666 674 O
access 20 26 675 681 O
to 27 29 682 684 O
receive 30 37 685 692 O
study 38 43 693 698 B-treatment
drug 44 48 699 703 I-treatment
, 48 49 703 704 O
and 50 53 705 708 O
to 54 56 709 711 O
allow 57 62 712 717 O
blood 63 68 718 723 O
sampling 69 77 724 732 O
at 78 80 733 735 O
a 81 82 736 737 O
site 83 87 738 742 O
separate 88 96 743 751 O
from 97 101 752 756 O
the 102 105 757 760 O
study 106 111 761 766 O
drug 112 116 767 771 O
infusion 117 125 772 780 O
site 126 130 781 785 O

